SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
PT. Chandra Asri Petrochemical Tbk (PTCAY) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 21/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PTCAY
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio17.72
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.10
Book Value / Share$0.00
Revenue / Share$2.51
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$0.04 |
$1.38B |
$26.34M |
1.9% |
| 2016 |
$0.41 |
$1.93B |
$300.02M |
15.5% |
| 2017 |
$0.42 |
$2.42B |
$318.62M |
13.2% |
| 2018 |
$0.23 |
$2.54B |
$181.65M |
7.1% |
| 2019 |
$0.03 |
$1.88B |
$22.88M |
1.2% |
| 2020 |
$0.07 |
$1.81B |
$51.35M |
2.8% |
| 2021 |
$0.18 |
$2.58B |
$151.99M |
5.9% |
| 2022 |
$-0.21 |
$2.38B |
$-149.4M |
-6.3% |
| 2023 |
$-0.05 |
$2.16B |
$-33.58M |
-1.6% |
| 2024 |
$-0.10 |
$1.79B |
$-69.16M |
-3.9% |
